Axsome Therapeutics | 8-K: Current report

Mar 5 20:05

Axsome Therapeutics | 8-K: Current report

Mar 3 20:06

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahony Susan

Feb 26 09:06

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER

Feb 26 09:01

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E

Feb 26 09:01

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maizel Ari

Feb 26 09:01

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murdock Hunter R.

Feb 26 09:01

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzie Nick

Feb 26 08:56

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.

Feb 26 08:56

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer TABUTEAU HERRIOT

Feb 26 08:56

Axsome Therapeutics | 10-K: FY2024 Annual Report

Feb 19 06:16

Axsome Therapeutics | 8-K: Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 18 20:11

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzie Nick

Feb 15 10:24

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 15 05:15

Axsome Therapeutics | SCHEDULE 13G/A: Others

Feb 14 22:04

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 14 05:06

Axsome Therapeutics | 8-K: Current report

Feb 10 20:11

Axsome Therapeutics | 8-K: Current report

Feb 1 02:07

Axsome Therapeutics | 8-K: Current report

Jan 13 20:28

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coleman Mark

Jan 7 05:11